In NSCLC, it was described as a tumor suppressor acting on insulin growth factor (IGF)-1R53, being involved in tumor growth and metastasis through STAT3 and Neuropilin 1 downregulation [122,123,124]. Here, STAT3 is linked to neoplasm.